CME vs TW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

CME

34.6
AI Score
VS
CME Wins

TW

32.0
AI Score

Investment Advisor Scores

CME

35score
Recommendation
SELL

TW

32score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CME TW Winner
Forward P/E 21.5517 29.6736 CME
PEG Ratio 4.6223 1.8571 TW
Revenue Growth 0.8% 9.0% TW
Earnings Growth 2.5% 19.7% TW
Tradestie Score 34.6/100 32.0/100 CME
Profit Margin 63.4% 40.7% CME
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

CME 1M: +9.6% · 3M: -9.4% TW 1M: +5.0% · 3M: -3.2%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 64.4 · Price: $269.80

TW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.5 · Price: $106.29

Fundamentals Snapshot

Metric CME TW
Market Cap
Forward P/E 20.9 23.2
Trailing P/E 22.2 25.2
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.9%
Operating Margin 0.7% 0.4%
EPS 12.02 4.19
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.